Multinodular Goiter Treatment: From Observation to Surgery

Multinodular goiter (MNG) management is individualized by size, symptoms, thyroid function, and malignancy risk.

1. Conservative Management

  • Observation: Asymptomatic, euthyroid, <4 cm, no suspicious US features. Monitor q6–12 mo (US + TSH).
  • Levothyroxine Suppression (TSH 0.1–0.5 mIU/L): Modest volume reduction (~15–30%) in iodine-sufficient areas; less effective long-term. Risks: atrial fibrillation, bone loss (esp. postmenopausal). Not routinely recommended (ATA).
  • Radioiodine (RAI): 30–50% volume reduction over 1–2 yrs. Best for toxic MNG, elderly, surgical high-risk. Hypothyroidism inevitable.

2. Surgical Indications

  • Compressive Symptoms: Dyspnea, dysphagia, stridor, Pemberton's sign (arms up → facial congestion).
  • Toxic MNG: Hyperthyroidism uncontrolled by meds/RAI.
  • Suspicious Nodules: Bethesda III–VI on FNA, or growing despite benign FNA.
  • Cosmetic Concern: Patient-driven, after counseling.
  • Retrosternal Extension: Mediastinal component (CT-confirmed).

3. Surgical Options

ProcedureExtentIndication
Total ThyroidectomyAll thyroid tissueBilateral disease, cancer risk, Graves, reoperation
Subtotal/Near-Total~3–5g remnant each sideHistorical; less favored (recurrence, devascularization)
Lobectomy/IsthmusectomyOne lobe ± isthmusUnilateral dominant nodule, benign

Critical Technical Points

  • RLN Identification: Routine visualization ± IONM (nerve monitoring).
  • Parathyroid Preservation: In situ or autotransplant (forearm).
  • Hemostasis: Meticulous – hematoma = airway emergency.

Postop

  • Calcium + Vitamin D prophylaxis (prevents hypocalcemia).
  • Levothyroxine if total thyroidectomy (TSH target 0.5–2.5).
  • Pathology review → further treatment if cancer.

Decision Maker: Endocrinologist + High-volume thyroid surgeon (>50 thyroids/yr).

Gonorrhea - Related Articles